Case Report
Accepted on 30 Oct 2025
A Case Report Focusing on Diagnosis and Intervention of Chronic Myeloid Leukemia in Blast Crisis (Acute Megakaryoblastic Leukemia Subtype)
in Hematologic Malignancies
Frontiers in Oncology
Type at least 3 characters
1,964 articles
Original Research
Published on 30 Oct 2025
Testicular lymphoma of 63 patients: a Chinese retrospective, real-world study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1652944
- 268 views
Editorial
Published on 30 Oct 2025
Editorial: Metabolic dysregulation in hematological malignancies: emerging insights and therapeutic implications
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1701952
- 188 views
Systematic Review
Published on 30 Oct 2025
Addition of daratumumab to standard triplet regimens achieved better survival in newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1619115
- 334 views
Case Report
Accepted on 29 Oct 2025
Case Report: Rare Adverse Events Following CAR-T Therapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
in Hematologic Malignancies
Frontiers in Oncology
- 235 views
Case Report
Accepted on 29 Oct 2025
Primary non-Hodgkin lymphoma in the muscle of left lower extremity: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
Brief Research Report
Accepted on 29 Oct 2025
Retrospective Analysis of Sorafenib Combined with Interferon α-1b, Interleukin-2, and Thalidomide as Maintenance Therapy in FLT3-ITD-Positive Acute Myeloid Leukemia
in Hematologic Malignancies
Frontiers in Oncology
Case Report
Accepted on 28 Oct 2025
Case report: iatrogenic dyspnea and respiratory failure in a multiple myeloma patient treated with Carfilzomib
in Hematologic Malignancies
Frontiers in Oncology
- 132 views
Methods
Accepted on 28 Oct 2025
Proposed Observational Study Protocol for Early Differentiation of Cytokine Release Syndrome and Sepsis in CAR-T Recipients with Haematological Malignancies Using the IL-6/PCT Ratio: The DRACARYS Study
in Hematologic Malignancies
Frontiers in Oncology
- 153 views
Original Research
Published on 28 Oct 2025
Efficacy and safety of hetrombopag in the treatment of chemotherapy-related thrombocytopenia in solid tumors: a retrospective study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1670029
- 394 views
Original Research
Published on 28 Oct 2025
The prognostic significance of incomplete hematological recovery in pediatric patients with low/intermediate risk AML and negative MRD after induction 1
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1661036
- 344 views
Case Report
Published on 27 Oct 2025
Case Report: Venetoclax combined with hypomethylating agents for the treatment of newly diagnosed with mixed-phenotype acute leukemia and a literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1693061
- 290 views
Editorial
Published on 27 Oct 2025
Editorial: Immunotherapy and cell therapy for patients with relapsed and refractory acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1691911
- 435 views
Original Research
Published on 27 Oct 2025
Post-progression outcomes following BCMA-directed CAR T-cell therapy in myeloma: impact of extramedullary and paramedullary disease
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1663814
- 535 views
Original Research
Accepted on 24 Oct 2025
Longitudinal Analysis of Usage and Public Awareness of Tyrosine Kinase Inhibitors for CML
in Hematologic Malignancies
Frontiers in Oncology
- 400 views
Brief Research Report
Accepted on 24 Oct 2025
Integrated Circle-Seq with RNA-Seq to Decipher the Quantity, Localization, and Functional Features of eccDNA in AML
in Hematologic Malignancies
Frontiers in Oncology
- 301 views